Urology
sponsor

Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Health related quality of life after radical cystectomy: Comparison of ileal conduit to continent orthotopic neobladder
European Journal of Surgical Oncology, 07/02/09

Autorino R et al. - Few differences between ileal conduit and orthotopic bladder substitution have been detected. Thus, the assumption that continent reconstruction provides better HRQOL than ileal conduit diversion cannot be supported. Patient education and active participation in treatment decisions seem to be the key to postoperative satisfaction.

Related Articles

Radical cystectomy in the elderly patient: a contemporary comparison of perioperative complications in a single institution series
World Journal of Urology, 10/26/09    Relevance Score: 69%

Orthotopic sigmoid neobladder after radical cystectomy: assessment of complications, functional outcomes and quality of life in 82 Japanese patients
BJU International, 11/09/09    Relevance Score: 67%

Fast Track Program in Patients Undergoing Radical Cystectomy: Results in 362 Consecutive Patients
Journal of the American College of Surgeons, 10/30/09    Relevance Score: 67%

Aggregate Lymph Node Metastasis Diameter and Survival After Radical Cystectomy for Invasive Bladder Cancer
Urology, 10/21/09    Relevance Score: 66%

Prognostic Significance of Hydronephrosis in Bladder Cancer Treated by Radical Cystectomy
Urologia Internationalis, 10/20/09    Relevance Score: 66%

Today in Bladder...keeping you current

Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09

Laparoscopic versus open radical cystectomy for the management of bladder cancer: Mid-term oncological outcome
International Journal of Urology, 12/04/09

XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy
Journal of Cancer Research & Clinical Oncology, 12/04/09

 See all of Bladder

Today in Oncology...keeping you current

Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09

Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09

The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09

 See all of Oncology